Home Tags IND

Tag: IND

StemCyte Receives IND Clearance Of Mononuclear Stem Cells In Spinal Cord Injury Clinical Trials

On December 14, 2018, the U.S. Food and Drug Administration (FDA), approved StemCyte’s Phase II Investigational New Drug (IND) application for Allogeneic Human Leukocyte Antigen (HLA)-Matched Umbilical Cord Blood Mononuclear Stem Cells (UCBMNC) (MC001) for the treatment of spinal cord injury. Founded in 1997,...

⭐ Recently Featured

🔥 Popular Posts